CN102961737A - 多肽dz24在制备治疗山羊细菌或真菌性炎症药物中的应用 - Google Patents

多肽dz24在制备治疗山羊细菌或真菌性炎症药物中的应用 Download PDF

Info

Publication number
CN102961737A
CN102961737A CN2012105338392A CN201210533839A CN102961737A CN 102961737 A CN102961737 A CN 102961737A CN 2012105338392 A CN2012105338392 A CN 2012105338392A CN 201210533839 A CN201210533839 A CN 201210533839A CN 102961737 A CN102961737 A CN 102961737A
Authority
CN
China
Prior art keywords
polypeptide
medicine
bacteria
application
goat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012105338392A
Other languages
English (en)
Inventor
赖仞
容明强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming Institute of Zoology of CAS
Original Assignee
Kunming Institute of Zoology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming Institute of Zoology of CAS filed Critical Kunming Institute of Zoology of CAS
Priority to CN2012105338392A priority Critical patent/CN102961737A/zh
Publication of CN102961737A publication Critical patent/CN102961737A/zh
Pending legal-status Critical Current

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

本发明涉及多肽DZ24在制备治疗山羊细菌或真菌性炎症药物中的应用,属于多肽技术领域。分子量为2620.06 Da,等电点为 9.11,氨基酸序列为DGVKVRTCTS QKAVCFFGCP PGYR的多肽DZ24在制备治疗山羊细菌或真菌性炎症药物中的应用。本发明的效果在于:用多肽DZ24制备的治疗山羊细菌或真菌性炎症的药物,抑菌效果明显。

Description

多肽DZ24在制备治疗山羊细菌或真菌性炎症药物中的应用
技术领域:
本发明涉及多肽DZ24在制备治疗山羊细菌或真菌性炎症药物中的应用,属于多肽技术领域。
背景技术:
抗生素的广泛应用,耐药菌株和多重耐药菌株日益增加,临床抗感染治疗已面临严峻挑战,寻找广谱高效的抗细菌、抗病毒药物,仍然是一个十分艰巨的任务。抗菌肽是动物体内极为重要的先天免疫物质,是一种具有高效抗菌、抗病毒、免疫功能的生物活性因子。抗菌肽是宿主非特异性免疫防御系统产生的一类对抗外源性病原体的肽类活性物质,是天然免疫的效应分子。研究表明,抗菌肽有着与传统抗生素完全不同的作用机制,不易诱导耐药菌株的产生;抗菌谱广,对细菌、真菌、病毒、原虫及癌细胞均有作用。在家禽上,已经发现了3个家族的抗菌肽包括cathelicidin, liver-expressed antimicrobial peptide (LEAP), and β-defensin。 这些抗菌肽对于家禽抵抗细菌性、病毒性疾病具有至关重要的作用。相关这些基因的突变或者缺失对于家禽抗微生物感染的能力将有显著的影响。这些些抗菌肽除了具有广谱抗菌活性,同时还有高效的抗真菌、抗病毒、抗原虫和(或)抗肿瘤活性,如Bat5和IMc7能杀灭钩端螺旋体,对白色念珠菌、隐球菌和包膜病毒和寄生虫都有较好的杀灭作用;一些抗菌肽对疱疹病毒、流感病毒、艾滋病病毒等有囊膜病毒有明显的杀伤力。此外,有些抗菌肽同时还具有多种其他的调控功能,如Cathelicidin还具有促进伤口愈合、组织损伤修复、化学趋化作用、促血管生成和抗寄生虫等功能,在调节动物机体免疫上有着重要生物学活性。
发明内容:
本发明的目的在于提供多肽DZ24在制备治疗山羊细菌或真菌性炎症药物中的应用。
本发明的所用的一种来自山羊的多肽DZ24采用常规的化学合成的方法获得,多肽DZ24的分子量为2620.06 Da,等电点为 9.11,氨基酸序列为DGVKVRTCTS QKAVCFFGCP PGYR。该多肽DZ24在制备治疗山羊细菌或真菌性炎症药物中的应用
本发明的内容的抗菌试验,其试验方案为常规方法,具体如下:
将已制备好的高柱肉汤琼脂培养基加热熔化后,待冷却至50℃左右时,加入肉汤培养基菌液1mL(经过恒温37℃培养18小时的菌液),轻轻摇动,使之均匀.然后倒入无菌的平皿内,轻轻晃动平皿,以使培养基均匀地平铺在平皿上,待冷却凝固后,用消毒过的镊子将青霉素干纸片、链霉素干纸片、四环素干纸片、磺胺嘧啶干纸片整齐有顺序的放入平血内,盖上陶瓦盖,标好记号置37℃恒温培养箱内培养24小时.24小时后取出培养基,用卡尺量取抑菌圈大小并记录之,并比较不同抗菌药物对不同细菌的作用强度。
本发明的效果在于:用多肽DZ24制备的治疗山羊细菌或真菌性炎症的药物,抑菌效果明显。
附图说明:
图1为山羊的多肽DZ24对白色念珠菌的抑制效果。
具体实施方式:
下面结合附图对本发明作进一步的详细说明。
实施例所用的一种来自山羊的多肽DZ24采用常规的化学合成的方法获得,多肽DZ24的分子量为2620.06 Da,等电点为 9.11,氨基酸序列为DGVKVRTCTS QKAVCFFGCP PGYR。
多肽DZ24的抗菌试验具体步骤同发明内容部分的描述。
实施例1 :
多肽DZ24对白色念珠菌的抑制作用。
取8μg/ml、以及15μg/ml多肽DZ24进行抑菌试验。结果为:8ug/ml多肽DZ24仅有较弱的抑菌效果(图1-B),15ug/ml多肽DZ24抑菌效果很明显(图1-C),图1-A为一种来自山羊的多肽DZ24抑菌效果试验对照。
实施例2 :
多肽DZ24对不同细菌的最低抑菌浓度。
取不同浓度的多肽DZ24分别抑制大肠杆菌、绿脓杆菌、金色葡萄球菌,枯草杆菌以及白色念珠菌。其中表1为该多肽对大肠杆菌、绿脓杆菌、金色葡萄球菌,枯草杆菌以及白色念珠菌的最低抑制浓度分别为:13.54 μg/ml, 34.91 μg/ml, 11.78 μg/ml, 10.39 μg/ml, 6.31μg/ml。
表1
Figure BDA0000257115951
SEQUENCE LISTING
 
<110>  中国科学院昆明动物研究所
 
<120>  多肽DZ24在制备治疗山羊细菌或真菌性炎症药物中的应用
 
<130>  1
 
<160>  1    
 
<170>  PatentIn version 3.3
 
<210>  1
<211>  24
<212>  PRT
<213>  Capra ibex
 
<400>  1
 
Asp Gly Val Lys Val Arg Thr Cys Thr Ser Gln Lys Ala Val Cys Phe
1               5                   10                  15     
 
 
Phe Gly Cys Pro Pro Gly Tyr Arg
            20                 
 
 

Claims (1)

1.分子量为2620.06 Da,等电点为 9.11,氨基酸序列为DGVKVRTCTSQKAVCFFGCP PGYR的多肽DZ24在制备治疗山羊细菌或真菌性炎症药物中的应用。
CN2012105338392A 2012-12-12 2012-12-12 多肽dz24在制备治疗山羊细菌或真菌性炎症药物中的应用 Pending CN102961737A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012105338392A CN102961737A (zh) 2012-12-12 2012-12-12 多肽dz24在制备治疗山羊细菌或真菌性炎症药物中的应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012105338392A CN102961737A (zh) 2012-12-12 2012-12-12 多肽dz24在制备治疗山羊细菌或真菌性炎症药物中的应用

Publications (1)

Publication Number Publication Date
CN102961737A true CN102961737A (zh) 2013-03-13

Family

ID=47792356

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012105338392A Pending CN102961737A (zh) 2012-12-12 2012-12-12 多肽dz24在制备治疗山羊细菌或真菌性炎症药物中的应用

Country Status (1)

Country Link
CN (1) CN102961737A (zh)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004063219A1 (en) * 2003-01-13 2004-07-29 Ares Trading S.A. Defensin protins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004063219A1 (en) * 2003-01-13 2004-07-29 Ares Trading S.A. Defensin protins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MA DEYING等: "Identification ,expression and activity analyses of five novel duck beta-defensins", 《PLOS ONE》 *
盛金良 等: "绵羊防御素(SBD1)mRNA在不同发育阶段的组织分布和定量分析", 《畜牧兽医学报》 *

Similar Documents

Publication Publication Date Title
E Greber et al. Antimicrobial peptides under clinical trials
Menousek et al. Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300
Feng et al. Functional synergy of α-helical antimicrobial peptides and traditional antibiotics against Gram-negative and Gram-positive bacteria in vitro and in vivo
Mohamed et al. Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides
JP7267251B2 (ja) 抗菌組成物及び医薬組成物
JP4310107B2 (ja) 生物活性を有する短ペプチド及び該ペプチドの使用方法
CN102702333B (zh) 抗耐药性病原菌感染多肽及其用途
BR112012024676B1 (pt) Peptídeo, composição, e, substrato
Nešuta et al. Antimicrobial peptide from the wild Bee Hylaeus signatus venom and its analogues: structure–activity study and synergistic effect with antibiotics
Li et al. An enhanced variant designed from DLP4 cationic peptide against Staphylococcus aureus CVCC 546
Jeong et al. Antibiotic and synergistic effect of Leu–Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis
Cao et al. Killing Streptococcus mutans in mature biofilm with a combination of antimicrobial and antibiofilm peptides
Teixeira et al. In vivo antimicrobial evaluation of an alanine-rich peptide derived from Pleuronectes americanus
Rodrigues et al. Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence
Helaly et al. Dexpanthenol and propolis extract in combination with local antibiotics for treatment of Staphylococcal and Pseudomonal wound infections.
CN102940874B (zh) 小分子多肽cw14在制备山羊抗菌药物中的应用
CN104524547B (zh) 菌丝霉素在抑制无乳链球菌中的应用
Vineethkumar et al. Post-translationally modified frog skin-derived antimicrobial peptides are effective against Aeromonas sobria
CN102940876B (zh) 多肽gh27在制备预防及治疗山羊腹泻药物中的应用
CN102935223B (zh) 多肽gc25在制备治疗抗感染药物中的应用
CN102940877B (zh) 多肽dm29在制备增加山羊天然免疫功能药物中的应用
Yuan et al. In vitro and in vivo antibacterial activity of a lysine-rich scorpion peptide derivative
CN102961737A (zh) 多肽dz24在制备治疗山羊细菌或真菌性炎症药物中的应用
CN102961736A (zh) 山羊抗菌肽gc41的应用
Avram et al. Evaluation of the therapeutic properties of mastoparan-and sifuvirtide-derivative antimicrobial peptides using chemical structure-function relationship-in vivo and in silico approaches

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130313